{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:14:24Z","timestamp":1791357264225,"version":"4.3.1"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.brainres.2019.146597","type":"journal-article","created":{"date-parts":[[2019,12,11]],"date-time":"2019-12-11T02:41:29Z","timestamp":1576032089000},"page":"146597","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Suvorexant to treat alcohol use disorder and comorbid insomnia: Plan for a phase II trial"],"prefix":"10.1016","volume":"1728","author":[{"given":"Erin J.","family":"Campbell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Norman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne","family":"Bonomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Lawrence","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.brainres.2019.146597_b0005","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1124\/jpet.102.048025","article-title":"Distinct recognition of OX1 and OX2 receptors by orexin peptides","volume":"305","author":"Ammoun","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.brainres.2019.146597_b0010","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3389\/fnins.2014.00033","article-title":"Orexin-1 and orexin-2 receptor antagonists reduce ethanol self-administration in high-drinking rodent models","volume":"8","author":"Anderson","year":"2014","journal-title":"Front. Neurosci."},{"issue":"4","key":"10.1016\/j.brainres.2019.146597_b0015","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1300\/J069v26n04_06","article-title":"Treatment options for sleep disturbances during alcohol recovery","volume":"26","author":"Arnedt","year":"2007","journal-title":"J. Addict. Dis."},{"issue":"4","key":"10.1016\/j.brainres.2019.146597_b0020","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.15288\/qjsa.1974.35.1230","article-title":"Clinical correlates of reported sleep disturbance in alcoholics","volume":"35","author":"Baekeland","year":"1974","journal-title":"Q. J. Stud. Alcohol"},{"key":"10.1016\/j.brainres.2019.146597_b0025","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/adb.12139","article-title":"Anterior thalamic paraventricular nucleus is involved in intermittent access ethanol drinking: Role of orexin receptor 2","volume":"20","author":"Barson","year":"2015","journal-title":"Addict. Biol."},{"issue":"6","key":"10.1016\/j.brainres.2019.146597_b0030","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.alcohol.2011.02.306","article-title":"Orexin A expression and promoter methylation in patients with alcohol dependence comparing acute and protracted withdrawal","volume":"45","author":"Bayerlein","year":"2011","journal-title":"Alcohol"},{"issue":"2","key":"10.1016\/j.brainres.2019.146597_b0035","first-page":"110","article-title":"Alcohol's effects on sleep in alcoholics","volume":"25","author":"Brower","year":"2001","journal-title":"Alcohol. Res. Health"},{"key":"10.1016\/j.brainres.2019.146597_b0040","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1176\/appi.ajp.158.3.399","article-title":"Insomnia, self-medication, and relapse in alcoholism","volume":"158","author":"Brower","year":"2001","journal-title":"Am. J. Psychiatry"},{"issue":"6","key":"10.1016\/j.brainres.2019.146597_b0045","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S1087-0792(03)90005-0","article-title":"Insomnia, alcoholism and relapse","volume":"7","author":"Brower","year":"2003","journal-title":"Sleep Med. Rev."},{"issue":"4","key":"10.1016\/j.brainres.2019.146597_b0050","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.alcohol.2014.12.003","article-title":"Assessment and treatment of insomnia in adult patients with alcohol use disorders","volume":"49","author":"Brower","year":"2015","journal-title":"Alcohol."},{"issue":"8","key":"10.1016\/j.brainres.2019.146597_b0055","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1111\/j.1530-0277.2008.00706.x","article-title":"A randomized double-blind pilot trial of gabapentin vs. placebo to treat alcohol dependence and comorbid insomnia","volume":"32","author":"Brower","year":"2008","journal-title":"Alcohol. Clin. Exp. Res."},{"issue":"9","key":"10.1016\/j.brainres.2019.146597_b0060","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1017\/S1461145713000333","article-title":"Central orexin (hypocretin) 2 receptor antagonism reduces ethanol self-administration, but not cue-conditioned ethanol-seeking, in ethanol-preferring rats","volume":"16","author":"Brown","year":"2013","journal-title":"Int. J Neuropsychopharmacol."},{"issue":"3","key":"10.1016\/j.brainres.2019.146597_b0065","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/adb.12251","article-title":"Orexin-1 receptor signalling in the prelimbic cortex and ventral tegmental area regulates cue-induced reinstatement of ethanol-seeking in iP rats","volume":"21","author":"Brown","year":"2016","journal-title":"Addict. Biol."},{"issue":"6","key":"10.1016\/j.brainres.2019.146597_b0070","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1007\/s00213-018-4887-7","article-title":"New steps for treating alcohol use disorder","volume":"235","author":"Campbell","year":"2018","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.brainres.2019.146597_b0075","unstructured":"Campbell, E.J., Marchant, N.J., Lawrence, A.J. (2018). A sleeping giant: Suvorexant for the treatment of alcohol use disorder? Brain Research. In press."},{"key":"10.1016\/j.brainres.2019.146597_b0080","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0092-8674(00)81973-X","article-title":"Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation","volume":"98","author":"Chemelli","year":"1999","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.brainres.2019.146597_b0085","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1097\/01.ALC.0000141915.56236.40","article-title":"Association of sleep disturbance with chronicity and remission of alcohol dependence: data from a population-based prospective study","volume":"28","author":"Crum","year":"2004","journal-title":"Alcohol. Clin. Exp. Res."},{"issue":"1","key":"10.1016\/j.brainres.2019.146597_b0090","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1073\/pnas.95.1.322","article-title":"The hypocretins: Hypothalamus-specific peptides with neuroexcitatory activity","volume":"95","author":"de Lecea","year":"1998","journal-title":"Proc. Natl Acad. Sci. U.S.A."},{"issue":"4","key":"10.1016\/j.brainres.2019.146597_b0095","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/acer.12006","article-title":"Alcohol and sleep I: effects on normal sleep","volume":"37","author":"Ebrahim","year":"2013","journal-title":"Alcohol. Clin. Exp. Res."},{"issue":"3","key":"10.1016\/j.brainres.2019.146597_b0100","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1590\/S1516-44462009000300013","article-title":"Complaints of insomnia in hospitalized alcoholics","volume":"31","author":"Escobar-Cordoba","year":"2009","journal-title":"Rev. Bras. Psiquiatr."},{"key":"10.1016\/j.brainres.2019.146597_b0105","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1001\/jama.1989.03430110069030","article-title":"Epidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention?","volume":"262","author":"Ford","year":"1989","journal-title":"JAMA"},{"key":"10.1016\/j.brainres.2019.146597_b0110","doi-asserted-by":"crossref","first-page":"10911","DOI":"10.1073\/pnas.96.19.10911","article-title":"Orexin A activates locus coeruleus cell firing and increases arousal in the rat","volume":"96","author":"Hagan","year":"1999","journal-title":"PNAS"},{"issue":"2","key":"10.1016\/j.brainres.2019.146597_b0115","doi-asserted-by":"crossref","first-page":"184","DOI":"10.9758\/cpn.2018.16.2.184","article-title":"Assessment of switching to suvorexant versus the use of add-on suvorexant in combination with benzodiazepine receptor agonists in insomnia patients: A retrospective study","volume":"16","author":"Hatano","year":"2018","journal-title":"Clin. Psychopharmacol. Neurosci."},{"key":"10.1016\/j.brainres.2019.146597_b0120","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/7854_2016_56","article-title":"Role of the Orexin\/Hypocretin System in Stress-Related Psychiatric Disorders","volume":"33","author":"James","year":"2017","journal-title":"Curr. Top Behav. Neurosci."},{"key":"10.1016\/j.brainres.2019.146597_b0125","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.brainres.2011.03.045","article-title":"The orexin(1) receptor antagonist SB-334867 dissociates the motivational properties of alcohol and sucrose in rats","volume":"1391","author":"Jupp","year":"2011","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2019.146597_b0130","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1111\/j.1530-0277.1998.tb05930.x","article-title":"Alteration in the sensitivity of GABAA receptors to allosteric modulatory drugs in rat hippocampus after chronic intermittent ethanol treatment","volume":"2","author":"Kang","year":"1998","journal-title":"Alcohol. Clin. Exp. Res."},{"issue":"Pt A","key":"10.1016\/j.brainres.2019.146597_b0135","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.neuropharm.2016.07.006","article-title":"Nucleus incertus Orexin2 receptors mediate alcohol seeking in rats","volume":"110","author":"Kastman","year":"2016","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.brainres.2019.146597_b0140","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41386-019-0446-0","article-title":"Alcohol use disorder and sleep disturbances: A feed-forward allostatic framework","volume":"45","author":"Koob","year":"2020","journal-title":"Neuropsychopharm"},{"key":"10.1016\/j.brainres.2019.146597_b0145","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1523\/JNEUROSCI.23-01-00007.2003","article-title":"Excitation of ventral tegmental area dopaminergic and nondopaminergic neurons by orexins\/hypocretins","volume":"23","author":"Korotkova","year":"2003","journal-title":"J. Neurosci."},{"issue":"6","key":"10.1016\/j.brainres.2019.146597_b0150","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1038\/sj.bjp.0706789","article-title":"The orexin system regulates alcohol-seeking in rats","volume":"148","author":"Lawrence","year":"2006","journal-title":"Br. J. Pharmacol."},{"issue":"88","key":"10.1016\/j.brainres.2019.146597_b0155","article-title":"Nucleus accumbens shell orexin-1 receptors are critical mediators of binge intake in excessive-drinking individuals","volume":"13","author":"Lei","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.brainres.2019.146597_b0160","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0092-8674(00)81965-0","article-title":"The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene","volume":"98","author":"Lin","year":"1999","journal-title":"Cell"},{"issue":"22","key":"10.1016\/j.brainres.2019.146597_b0165","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1001\/jama.2017.4760","article-title":"More Treatments on Deck for Alcohol Use Disorder","volume":"317","author":"Lyon","year":"2017","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.brainres.2019.146597_b0170","first-page":"24","article-title":"Self-reported sleep, sleepiness, and repeated alcohol withdrawals: a randomized, double blind, controlled comparison of lorazepam vs gabapentin","volume":"3","author":"Malcolm","year":"2007","journal-title":"J. Clin. Sleep Med."},{"key":"10.1016\/j.brainres.2019.146597_b0175","doi-asserted-by":"crossref","first-page":"807","DOI":"10.5665\/sleep.1880","article-title":"Cortical GABA levels in primary insomnia","volume":"35","author":"Morgan","year":"2012","journal-title":"Sleep"},{"issue":"Pt A","key":"10.1016\/j.brainres.2019.146597_b0180","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.brainres.2016.10.018","article-title":"Orexin\/hypocretin-1 receptor antagonism reduces ethanol self-administration and reinstatement selectively in highly-motivated rats","volume":"1654","author":"Moorman","year":"2017","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2019.146597_b0185","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0006-8993(00)02555-5","article-title":"Orexin-induced hyperlocomotion and stereotypy are mediated by the dopaminergic system","volume":"873","author":"Nakamura","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2019.146597_b0190","series-title":"Principles of Drug Addiction Treatment: A Research-Based","author":"NIDA","year":"2012"},{"key":"10.1016\/j.brainres.2019.146597_b0195","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0140-6736(99)05582-8","article-title":"Hypocretin (orexin) deficiency in human narcolepsy","volume":"355","author":"Nishino","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.brainres.2019.146597_b0200","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/79690","article-title":"A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains","volume":"6","author":"Peyron","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.brainres.2019.146597_b0205","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/978-1-4615-9038-5_25","article-title":"Sleep in alcoholic patients: Longitudinal findings","volume":"85B","author":"Rundell","year":"1977","journal-title":"Adv. Exp. Med. Biol."},{"issue":"4","key":"10.1016\/j.brainres.2019.146597_b0210","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0092-8674(00)80949-6","article-title":"Orexins and orexin receptors: A family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior","volume":"92","author":"Sakurai","year":"1998","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.brainres.2019.146597_b0215","article-title":"Effect of suvorexant on event-related oscillations and EEG sleep in rats exposed to chronic intermittent ethanol vapor and protracted withdrawal","volume":"42","author":"Sanchez-Alacez","year":"2019","journal-title":"Sleep"},{"issue":"5","key":"10.1016\/j.brainres.2019.146597_b0220","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0020360","article-title":"Pharmacogenetic modulation of orexin neurons alters sleep\/wakefulness states in mice","volume":"6","author":"Sasaki","year":"2011","journal-title":"PLoS ONE"},{"issue":"4","key":"10.1016\/j.brainres.2019.146597_b0225","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/JCP.0000000000000516","article-title":"Assessment of the abuse potential of the orexin receptor antagonist, suvorexant, compared with zolpidem in a randomized crossover study","volume":"36","author":"Schoedel","year":"2016","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.brainres.2019.146597_b0230","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s00213-010-2127-x","article-title":"Selective blockade of the orexin-2 receptor attenuates ethanol self-administration, place preference, and reinstatement","volume":"215","author":"Shoblock","year":"2010","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.brainres.2019.146597_b0235","doi-asserted-by":"crossref","first-page":"982","DOI":"10.15288\/qjsa.1971.32.982","article-title":"Sleep, psychological and clinical changes during alcohol withdrawal in NAD-treated alcoholics","volume":"32","author":"Smith","year":"1971","journal-title":"Q. J. Stud. Alc"},{"issue":"9","key":"10.1016\/j.brainres.2019.146597_b0240","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0044726","article-title":"The dual orexin\/hypocretin receptor antagonist, almorexant, in the ventral tegmental area attenuates ethanol self-administration","volume":"7","author":"Srinivasan","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.brainres.2019.146597_b0245","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0304-3940(99)00955-6","article-title":"Diurnal variation in orexin A immunoreactivity and prepro- orexin mRNA in the rat central nervous system","volume":"279","author":"Taheri","year":"2000","journal-title":"Neurosci. Letters"},{"key":"10.1016\/j.brainres.2019.146597_b0250","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.peptides.2016.12.008","article-title":"Increased plasma orexin-A levels in patients with insomnia disorder are not associated with prepro- orexin or orexin receptor gene polymorphisms","volume":"88","author":"Tang","year":"2017","journal-title":"Peptides"},{"issue":"4","key":"10.1016\/j.brainres.2019.146597_b0255","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.alcohol.2014.07.019","article-title":"Alcohol disrupts sleep homeostasis","volume":"49","author":"Thakkar","year":"2015","journal-title":"Alcohol"},{"issue":"3","key":"10.1016\/j.brainres.2019.146597_b0260","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0896-6273(00)00058-1","article-title":"Reduced number of hypocretin neurons in human narcolepsy","volume":"27","author":"Thannickal","year":"2000","journal-title":"Neuron"},{"issue":"3","key":"10.1016\/j.brainres.2019.146597_b0265","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/ADT.0b013e31812e6a3c","article-title":"Alcohol detoxification and relapse prevention using valproic acid versus gabapentin in alcohol-dependent patients","volume":"7","author":"Trevisan","year":"2008","journal-title":"Addict. Disord. Their Treat."},{"issue":"6","key":"10.1016\/j.brainres.2019.146597_b0270","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.biopsych.2015.04.021","article-title":"Activation of Hypocretin-1\/Orexin-A Neurons Projecting to the Bed Nucleus of the Stria Terminalis and Paraventricular Nucleus Is Critical for Reinstatement of Alcohol Seeking by Neuropeptide S","volume":"79","author":"Ubaldi","year":"2016","journal-title":"Biol. Psychiatry"},{"issue":"5","key":"10.1016\/j.brainres.2019.146597_b0275","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.yhbeh.2011.08.017","article-title":"Involvement of orexin in the regulation of stress, depression and reward in alcohol dependence","volume":"60","author":"von der Goltz","year":"2011","journal-title":"Horm. Behav."},{"key":"10.1016\/j.brainres.2019.146597_b0280","doi-asserted-by":"crossref","unstructured":"Walker, L. C., & Lawrence, A. J. (2016). The role of orexins\/\/hypocretins in alcohol use and abuse. In: Lawrence A.J., de Lecea L. (eds) Behavioral neuroscience of orexin\/hypocretin. Current Topics in Behavioral Neurosciences, vol 33. Springer, Cham.","DOI":"10.1007\/978-3-319-57535-3"},{"key":"10.1016\/j.brainres.2019.146597_b0285","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0163-8343(97)00056-X","article-title":"The morbidity of insomnia uncomplicated by psychiatric disorders","volume":"19","author":"Weissman","year":"1997","journal-title":"Gen. Hos. Psychiatry"},{"issue":"2","key":"10.1016\/j.brainres.2019.146597_b0290","doi-asserted-by":"crossref","DOI":"10.4172\/2168-975X.1000233","article-title":"Suvorexant as an adjunctive treatment for insomnia prior to discontinuation of benzodiazepines: Prevention of withdrawal syndrome and rebounr insomnia","volume":"6","author":"Yokoyama","year":"2017","journal-title":"Brain Disord Ther"},{"key":"10.1016\/j.brainres.2019.146597_b0295","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1523\/JNEUROSCI.23-08-03555.2003","article-title":"Circadian and homeostatic regulation of hypocretin in a primate model: Implications for the consolidation of wakefulness","volume":"23","author":"Zeitzer","year":"2003","journal-title":"J. Neurosci."}],"container-title":["Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899319306511?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899319306511?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T18:04:54Z","timestamp":1757786694000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006899319306511"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":59,"alternative-id":["S0006899319306511"],"URL":"https:\/\/doi.org\/10.1016\/j.brainres.2019.146597","relation":{},"ISSN":["0006-8993"],"issn-type":[{"value":"0006-8993","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Suvorexant to treat alcohol use disorder and comorbid insomnia: Plan for a phase II trial","name":"articletitle","label":"Article Title"},{"value":"Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainres.2019.146597","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"146597"}}